Legislation Search

H.R. 8160: Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 (H.R. 8160) aims to improve the understanding, diagnosis, and treatment of Premenstrual Dysphoric Disorder (PMDD). Here are the main points of the bill:

Findings

PMDD is a serious and chronic condition affecting approximately 5 to 8 percent of women and individuals assigned female at birth in their reproductive years.
The disorder is marked by severe mood changes, physical symptoms, and can significantly disrupt daily life, work, and education.
Despite being common and debilitating, PMDD is often underdiagnosed and stigmatized.
Improving awareness and access to effective treatment is key to enhancing the quality of life for those affected.

Research Initiatives

The bill directs the Secretary of Health and Human Services, through the National Institutes of Health, to:

Intensify research on PMDD, including its causes, risk factors, diagnosis, and effective treatments.
Support clinical trials aiming to develop better treatment options.
Include diverse populations in research efforts to better understand the disorder's impact across different communities.
Collect and publish data on PMDD prevalence and its economic and workforce impact.

Public Awareness and Education

The Secretary is mandated to launch a public health campaign focused on:

Raising awareness about the symptoms of PMDD and available treatments.
Reducing stigma related to menstrual health issues.
Encouraging timely medical consultations for individuals experiencing PMDD symptoms.

Additionally, the bill calls for the development and dissemination of educational materials for healthcare providers to ensure they can:

Correctly diagnose PMDD.
Differentiate it from other conditions.
Provide evidence-based care for patients.

Grants to Train Healthcare Professionals

The legislation authorizes the Secretary to award grants to eligible institutions, such as medical schools, nursing schools, and hospitals, for training healthcare professionals in:

Managing and treating PMDD.
Improving clinical training programs, including residencies and fellowships for various healthcare roles.

Reporting on Progress

Within two years of the bill's enactment, the Secretary must report to Congress on the advancements made in:

Research into PMDD.
Public education about PMDD.
Access to diagnosis and treatment of the disorder.

The proposed bill includes authorization for necessary funds for these initiatives from fiscal years 2027 through 2031, aimed at improving the understanding and management of PMDD.